| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 07/14/2023 | Phathom Pharmaceuticals, Inc. | PHAT | Grant | Common Stock | 200k | $0.00 | $0 | | 07/14/2023 |
| 07/14/2023 | Phathom Pharmaceuticals, Inc. | PHAT | Disposition | Stock Option | 175k | $32.20 | $5.6M | | 07/14/2023 |
| 07/14/2023 | Phathom Pharmaceuticals, Inc. | PHAT | Disposition | Stock Option | 225k | $39.11 | $8.8M | | 07/14/2023 |
| 05/31/2023 | Arcutis Biotherapeutics, Inc. | ARQT | Grant | Stock Option (right to buy) | 12.2k | $7.51 | $91.8k | | 05/31/2023 |
| 05/31/2023 | Arcutis Biotherapeutics, Inc. | ARQT | Grant | Common Stock | 4.4k | $0.00 | $0 | | 05/31/2023 |
| 03/10/2023 | Myovant Sciences Ltd. | MYOV | Disposition | Common Shares | 3.7k | $0.00 | $0 | | 03/10/2023 |
| 03/10/2023 | Myovant Sciences Ltd. | MYOV | Disposition | Stock Options (Right to Buy) | 33.8k | $11.30 | $382.5k | | 03/10/2023 |
| 03/10/2023 | Myovant Sciences Ltd. | MYOV | Disposition | Stock Options (Right to Buy) | 11.2k | $12.68 | $141.4k | | 03/10/2023 |
| 03/10/2023 | Myovant Sciences Ltd. | MYOV | Disposition | Stock Options (Right to Buy) | 22.5k | $13.14 | $295.6k | | 03/10/2023 |
| 03/10/2023 | Myovant Sciences Ltd. | MYOV | Disposition | Stock Options (Right to Buy) | 22.5k | $24.25 | $545.6k | | 03/10/2023 |
| 03/10/2023 | Myovant Sciences Ltd. | MYOV | Disposition | Stock Options (Right to Buy) | 5.2k | $7.65 | $40.2k | | 03/10/2023 |
| 03/10/2023 | Myovant Sciences Ltd. | MYOV | Disposition | Stock Options (Right to Buy) | 21.6k | $21.47 | $463.8k | | 03/10/2023 |
| 03/10/2023 | Myovant Sciences Ltd. | MYOV | Disposition | Stock Options (Right to Buy) | 21.1k | $22.71 | $479.1k | | 03/10/2023 |
| 01/20/2023 | Phathom Pharmaceuticals, Inc. | PHAT | Sale | Common Stock | 5.8k | $8.20 | $47.7k | | 01/19/2023 |
| 01/19/2023 | Phathom Pharmaceuticals, Inc. | PHAT | Grant | Common Stock | 97.5k | $0.00 | $0 | | 01/19/2023 |
| 01/19/2023 | Phathom Pharmaceuticals, Inc. | PHAT | Grant | Stock Option (Right to Buy) | 162.5k | $8.35 | $1.4M | | 01/19/2023 |
| 11/21/2022 | Phathom Pharmaceuticals, Inc. | PHAT | Sale | Common Stock | 1.5k | $9.60 | $14.6k | | 11/21/2022 |
| 09/01/2022 | Phathom Pharmaceuticals, Inc. | PHAT | Grant | Common Stock | 7.5k | $0.00 | $0 | | 09/01/2022 |
| 06/01/2022 | Arcutis Biotherapeutics, Inc. | ARQT | Grant | Common Stock | 4.3k | $0.00 | $0 | | 06/01/2022 |
| 06/01/2022 | Arcutis Biotherapeutics, Inc. | ARQT | Grant | Stock Option (Right to Buy) | 11.8k | $20.29 | $239.3k | | 06/01/2022 |
| 05/19/2022 | Phathom Pharmaceuticals, Inc. | PHAT | Grant | Common Stock | 12k | $0.00 | $0 | | 05/19/2022 |
| 05/13/2022 | Phathom Pharmaceuticals, Inc. | PHAT | Purchase | Common Stock | 20.5k | $7.41 | $151.8k | | 05/13/2022 |
| 01/19/2022 | Phathom Pharmaceuticals, Inc. | PHAT | Grant | Common Stock | 41.2k | $0.00 | $0 | | 01/19/2022 |
| 01/19/2022 | Phathom Pharmaceuticals, Inc. | PHAT | Grant | Stock Option (Right to Buy) | 206.2k | $15.21 | $3.1M | | 01/19/2022 |
| 11/05/2021 | Myovant Sciences Ltd. | MYOV | Grant | Stock Option (Right to Buy) | 21.1k | $22.71 | $479.1k | | 11/05/2021 |
| 09/09/2021 | Myovant Sciences Ltd. | MYOV | Sale | Common Shares | 4.8k | $25.58 | $124.1k | | 09/09/2021 |
| 09/09/2021 | Myovant Sciences Ltd. | MYOV | Exercise | Stock Option (Right to Buy) | 4.8k | $7.65 | $37.1k | | 09/09/2021 |
| 09/02/2021 | Myovant Sciences Ltd. | MYOV | Sale | Common Shares | 37.1k | $25.03 | $929.5k | | 09/01/2021 |
| 09/02/2021 | Myovant Sciences Ltd. | MYOV | Exercise | Stock Option (Right to Buy) | 37.1k | $7.65 | $284.1k | | 09/01/2021 |
| 09/01/2021 | Myovant Sciences Ltd. | MYOV | Exercise | Stock Option (Right to Buy) | 11.4k | $7.65 | $87k | | 09/01/2021 |
| 09/01/2021 | Myovant Sciences Ltd. | MYOV | Sale | Common Shares | 11.4k | $25.00 | $284.3k | | 09/01/2021 |
| 06/09/2021 | Arcutis Biotherapeutics, Inc. | ARQT | Grant | Stock Option (Right to Buy) | 13.4k | $27.77 | $371.9k | | 06/09/2021 |
| 03/22/2021 | Phathom Pharmaceuticals, Inc. | PHAT | Sale | Common Stock | 10.4k | $43.24 | $448.5k | | 03/22/2021 |
| 03/22/2021 | Phathom Pharmaceuticals, Inc. | PHAT | Sale | Common Stock | 1.1k | $44.08 | $50.3k | | 03/22/2021 |
| 03/22/2021 | Phathom Pharmaceuticals, Inc. | PHAT | Exercise | Stock Option (Right to Buy) | 11.5k | $6.95 | $80k | | 03/22/2021 |
|